Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase

Klaudia Kulak, Katarzyna Kuska, Lucie Colineau, Marina Mckay, Karolina Maziarz, Julia Slaby, Anna M Blom, Ben C King

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review


One of the hallmarks of type 1 but also type 2 diabetes is pancreatic islet inflammation, associated with altered pancreatic islet function and structure, if unresolved. IL-1β is a proinflammatory cytokine which detrimentally affects β-cell function. In the course of diabetes, complement components, including the central complement protein C3, are deregulated. Previously, we reported high C3 expression in human pancreatic islets, with upregulation after IL-1β treatment. In the current investigation, using primary human and rodent material and CRISPR/Cas9 gene-edited β-cells deficient in C3, or producing only cytosolic C3 from a noncanonical in-frame start codon, we report a protective effect of C3 against IL-1β-induced β-cell death, that is attributed to the cytosolic fraction of C3. Further investigation revealed that intracellular C3 alleviates IL-1β-induced β-cell death, by interaction with and inhibition of Fyn-related kinase (FRK), which is involved in the response of β-cells to cytokines. Furthermore, these data were supported by increased β-cell death in vivo in a β-cell-specific C3 knockout mouse. Our data indicate that a functional, cytoprotective association exists between FRK and cytosolic C3.

Antal sidor11
TidskriftProceedings of the National Academy of Sciences of the United States of America
StatusPublished - 2024 feb. 12

Ämnesklassifikation (UKÄ)

  • Endokrinologi och diabetes
  • Cell- och molekylärbiologi


Utforska forskningsämnen för ”Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här